Keyphrases
Schizophrenia
76%
Antipsychotics
44%
First-episode Psychosis
34%
Bipolar Disorder
27%
Schizophrenia Spectrum Disorders
26%
Schizophrenic Patients
25%
Patients with Schizophrenia
21%
Schizophrenia Symptoms
21%
Healthy Controls
20%
Nave
17%
Psychosis
17%
High Risk
17%
Psychopathology
16%
Family Risk
14%
High Resilience
14%
Negative Symptoms
12%
Denmark
12%
Ultra-high Risk for Psychosis
11%
Self-disorders
11%
Electroconvulsive Therapy
10%
Severe Mental Illness
9%
Randomized Controlled Trial
8%
Attention Deficit Hyperactivity Disorder
8%
Confidence Interval
8%
Clinical High Risk for Psychosis (CHR-P)
7%
Antidepressants
7%
Register Study
7%
Sensory Gating
7%
Clozapine
7%
Older children
7%
Randomized Clinical Trial
7%
Ultra-high Risk
7%
Placebo
7%
Autism
7%
7-year-olds
6%
Autism Spectrum Disorder
6%
Remission
6%
Meta-analysis
6%
First Episode
6%
Anomalous Self-experiences
5%
Cognitive Function
5%
Mismatch Negativity
5%
Cognitive Deficits
5%
Glutamate
5%
Clinical Outcomes
5%
Functional Magnetic Resonance Imaging
5%
Psychotic Symptoms
5%
Positive Symptoms
5%
Prepulse Inhibition
5%
Negative Syndrome
5%
Psychopathological
5%
Neurocognition
5%
Neuroscience
Dementia Praecox
100%
Antipsychotic
41%
Psychosis
17%
Bipolar Disorder
16%
Negative Syndrome
14%
Schizophrenia Spectrum Disorder
12%
Typical Antipsychotic
11%
Cognitive Disorders
10%
Pervasive Developmental Disorder
10%
Sensory Gating
10%
Attention Deficit Hyperactivity Disorder
9%
Positive Syndrome
8%
Placebo
8%
Cognitive Function
7%
Electroconvulsive Therapy
7%
Meta-Analysis
6%
Glutamic Acid
6%
Antidepressant
5%
Mood Disorder
5%
Working Memory
5%
Functional Magnetic Resonance Imaging
5%
Mismatch Negativity
5%
Depression
5%